C. van Krimpen - Concepedia

Concepedia

Author

C. van Krimpen

Reinier de Graaf Hospital

Also Known As

C Van Krimpen, C van Krimpen, C. Van Krimpen, C. van Krimpen, CEES VAN KRIMPEN, Cees van Krimpen

32

Publications

1.1K

Citations

11

H-Index

31

Concepts

All Affiliations

Reinier de Graaf Hospital Amsterdam UMC Location University of Amsterdam The Netherlands Cancer Institute Maastricht University Spaarne Ziekenhuis

CV

About

C. van Krimpen is an author at Reinier de Graaf Hospital specializing in medicine, cancer research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	816
2	Pathology	3	3	540
3	Health Sciences	1	1	24
4	Biostatistics	1	1	277
5	Cell Biology	1	1	87

C. van Krimpen

×

11

Publications

1.1K

Citations

11

H-Index

	Year	Citations
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER) Jolien M. Bueno-de-Mesquita, Wim H. van Harten, Valesca P. Retèl, The Lancet Oncology Prognostic BiomarkersBreast OncologyMedicine70-Gene SignaturePathology	2007	277
Validation of 70-gene prognosis signature in node-negative breast cancer Jolien M. Bueno-de-Mesquita, Sabine C. Linn, Richard Keijzer, Breast Cancer Research and Treatment Breast OncologyOncologyMedicinePathologyCancer Genomics	2008	176
Angiotensin II Receptor Blockade After Myocardial Infarction in Rats Jos F.M. Smits, C. van Krimpen, Regien G. Schoemaker, Journal of Cardiovascular Pharmacology HypertensionHeart FailureAngiotensin IiCardiovascular DiseaseMedicine	1992	175
Expression of c-Met and Heparan-Sulfate Proteoglycan Forms of CD44 in Colorectal Cancer Vera J.M. Wielenga, Robbert van der Voort, Taher E.I. Taher, American Journal Of Pathology Tumor BiologyOncologyMedicinePathologyColorectal Cancer	2000	87
Angiotensin II Receptor Blockade After Myocardial Infarction in Rats: Effects on Hemodynamics, Myocardial DNA Synthesis, and Interstitial Collagen Content Jos F.M. Smits, C. van Krimpen, Regien G. Schoemaker, Journal of Cardiovascular Pharmacology Cardiac MuscleHypertensionHeart FailureCardiovascular PharmacologyPharmacotherapy	1992	77
EXPRESSION OF MULTIDRUG RESISTANCE RELATED PROTEINS AND PROLIFERATIVE ACTIVITY IS INCREASED IN ADVANCED CLINICAL PROSTATE CANCER J.P. van Brussel, G.J. van Steenbrugge, C. van Krimpen, The Journal of Urology	2001	69
The prognostic influence of neuroendocrine differentiation in breast cancer: results of a long-term follow-up study C. van Krimpen, A.J.A. Elferink, C.A. Broodman, The Breast	2004	57
Constructive Technology Assessment (CTA) as a tool in Coverage with Evidence Development: The case of the 70-gene prognosis signature for breast cancer diagnostics Valesca P. Retèl, Jolien M. Bueno-de-Mesquita, Marjan Hummel, International Journal of Technology Assessment in Health Care	2009	40
Angiotensin I converting enzyme inhibitors and cardiac remodeling. C. van Krimpen, R G Schoemaker, Jack P.M. Cleutjens, PubMed	1991	38
THE PROGNOSTIC VALUE OF PRETREATMENT EXPRESSION OF ANDROGEN RECEPTOR AND BCL-2 IN HORMONALLY TREATED PROSTATE CANCER PATIENTS Marinus A. Noordzij, Jacques F. Bogdanowicz, C. van Krimpen, The Journal of Urology	1997	30

Page 1